Low-Dose CBD Pharmacokinetics Review (PubMed, 2026)

Tier 1: Established: peer-reviewed research or government health authority
Publisher: British Journal of Clinical Pharmacology (Warren, Osborn, Yates, O'Sullivan, 2026; PMID 42473010) · Published: September 16, 2026 · Accessed: September 16, 2026

Visit the source ↗

Claims this source supports

• Non-prescription CBD use has increased, with typical dose recommendations ranging from roughly 10 to 70 mg per day.
• The review examines the pharmacokinetics, pharmacodynamics and safety of low-dose CBD (defined as up to about 2.5 mg/kg or 175 mg/day).
• CBD pharmacokinetics vary between formulations and individuals, which limits how precisely any consumer dose can be generalised.